Global skin disease burden: A comparative study of dermatologic disease in Enugu State, Nigeria
- PMID: 40599992
- PMCID: PMC12209952
- DOI: 10.1016/j.jdin.2025.02.006
Global skin disease burden: A comparative study of dermatologic disease in Enugu State, Nigeria
Conflict of interest statement
Dr Brodell is a principal investigator for clinical trials (Novartis, Lilly, and Sanofi), the Corevitas psoriasis biologic registry, and owns stock in Veradermics Inc. Drs Morrissette, Nahar, Burrow, Offiah, Sullivan, Nnaji, and Mr. Smith have no financial interests to disclose.
Figures
Similar articles
-
Trends of tuberculosis prevalence and treatment outcome in an under-resourced setting: The case of Enugu state, South East Nigeria.Niger Med J. 2013 Nov;54(6):392-7. doi: 10.4103/0300-1652.126292. Niger Med J. 2013. PMID: 24665153 Free PMC article.
-
Coverage and predictors of enrollment in the state-supported health insurance schemes in Nigeria: a quantitative multi-site study.BMC Public Health. 2025 Jun 6;25(1):2125. doi: 10.1186/s12889-025-23329-4. BMC Public Health. 2025. PMID: 40481476 Free PMC article.
-
Population Survey on Contributing Factors to Sustained Prevalence of Sickle Cell Disease in Nigeria.West Afr J Med. 2025 Jan 30;42(1):44-51. West Afr J Med. 2025. PMID: 40544512
-
Estimating the prevalence, hospitalisation and mortality from type 2 diabetes mellitus in Nigeria: a systematic review and meta-analysis.BMJ Open. 2017 May 11;7(5):e015424. doi: 10.1136/bmjopen-2016-015424. BMJ Open. 2017. PMID: 28495817 Free PMC article.
-
Comparative severe dermatologic toxicities of immune checkpoint inhibitors in malignant melanoma: A systematic review and network meta-analysis.J Cosmet Dermatol. 2024 Apr;23(4):1165-1177. doi: 10.1111/jocd.16105. Epub 2023 Nov 27. J Cosmet Dermatol. 2024. PMID: 38013634
References
LinkOut - more resources
Full Text Sources